Published Materials
Thaddeus R. Tolleson, MD

Publications

• Tolleson TR, Harrington RA, Topol EJ. Adjunctive Therapies in Coronary Interventions. Textbook of Coronary Disease. Serruys PW, Leon MD, Colombo A, Kutryk JB editors. Martin Dunitz Publishing. 2000
• Tolleson TR, Sketch MH. The Role of Stenting in Treatment of Small Infarct-Related Arteries. Journal of Invasive Cardiology. 2000; 12:20-22
• Tolleson TR, Bittl J, Oshea JC, Saucedo J, Levine G, Blankenship JC, Tcheng J. Relationship between the Activated Clotting Time and Adverse Clinical Outcomes form ESPRIT/IMPACT II. Circulation 2000; 102(18): 3218-3219.
• Tolleson TR, Harrington RA, Newby LK, Berger PB, Van de Werf FD, Vahanian A. Fox KA, Moliterno DA, Califf RA, Topol EJ. Increased Rates of Stent Thrombosis Among Patients with Acute Coronary Syndromes: Insights form Two Large Oral Iib/IIIa Antagonist Trails. Journal of the American College of Cardiology. 2001; 40(4): 217-228
• O'Shea JC, Bahit MC, Tolleson TR, Cabell C, Dyke CK, Kaul A, McGuire DK, East MA. Highlights from the American Heart Association Annual Scientific Sessions: American Heart Journal. 2001; 141(2): 306-307.
• Tolleson TR, Harrison RH. Recent Clinical Trial in acute Coronary Syndromes Without Persistent ST Elevation. Evidence-Based Guidelines. Current Opinion in Cardiology 1999; 14:403-411.
• Tolleson TR, Harrington RH. The role of Thrombosis in Acute Coronary Syndromes and Coronary Interventions. Textbook of Interventional Cardiology - Glycoprotein Iib/IIIaInhibitors in Cardiovascular Disease. Lincoff AM, Topol EJ, Editors. The Humana Press, Inc. 1998.
• Tolleson TR, O'Connor CR. Sudden Death in Young Athletes. Epidemiology, Causes, and Recommendations for Screening Programs. American Heart Journal. 2001; 143(4): 219-225
• McGuire DK, O'Shea CO, Dyke DK, Kandzari DE, East MA, Tolleson TR, Highlights from the American College of Cardiology 49th annual Scientific Session. American Heart Journal 2000; 140(1): 181-1888.
• Feld S, Li G, Vaughn WK, Accad M, Tolleson TR, Swenson C, Ostro M, Smalling RW. Enhanced Thrombolysis, Reduced Coronary Reocclusion and Limitation of Infarct Size using Prostaglandin E1 in a Canine Thrombolysis Model. Journal of the American College of Cardiology 1994; 24(5): 1382-90.
• De la Serna FR, Tolleson TR, Crowley JM, Zidar JP. Intra-Arterial Thrombolysis and Abciximab for sub-acute Occlusion of the Distal Aorta. Catheterization and CardiovascularDiagnosis. 2001; 53(2): 264-268
• Wayne B. Batchelor MD, MHS; Thaddeus R. Tolleson, MD; Rhonda L. Larsen, P.A.C., M.H.S.; Ralph M. Mantell, R.C.V.T.; Patricia Dillard, B.A.; YAO Huang, MS; Marie Davidian, PhD; Daowen Zhang, PhD, Warren J. Cantor, MD; Michael H. Sketch, Jr., MD; E. Magnus Ohman, MD; Robert M. Califf, MD; Robert A. Harrington, MD. A Randomized Comparison of Platelet Inhibition during Abciximab, TiRofiban and Eptifibatide Infusion for Percutaneous Coronary Intervention: The COMPARE study. Circulation 2002.
• Cohen MG, Tolleson TR, Peter RH, Sketch MH. Percutaneous Coronary Interventions in Anomalous Right Coronary Arteries Arising from the Left Sinus of Valsalva. Catheterization & Cardiovascular. Interventions 55(1): 105-108, 2002.
• Batchelor WA, Tolleson TR, Harrington RA. Comparison of Measurement of Platelet Aggregation of Aggrastat, Reopro and Eptifibatide (The COMPARE study) Abstract. European Society of Cardiology. May 2000.

• Tolleson TR. Protective Effects of Glycoprotein Iib/IIIa Inhibitors in Patients with non-ST Elevation Myocardial Infarction. Monograph. Cor Therapeutics Inc.